BRA
Bender Robert & Associates Portfolio holdings
AUM
$448M
This Quarter Return
-8.42%
1 Year Return
+20.39%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$396M
AUM Growth
+$396M
(-4.4%)
Cap. Flow
+$21.6M
Cap. Flow
% of AUM
5.46%
Top 10 Holdings %
Top 10 Hldgs %
72.08%
Holding
49
New
3
Increased
19
Reduced
15
Closed
9
Top Buys
| 1 |
Apple
AAPL
|
$9.67M |
| 2 |
Chipotle Mexican Grill
CMG
|
$7.28M |
| 3 |
Palo Alto Networks
PANW
|
$6.19M |
| 4 |
lululemon athletica
LULU
|
$1.99M |
| 5 |
Meta Platforms (Facebook)
META
|
$1.57M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$5.74M |
| 2 |
Five Below
FIVE
|
$2.84M |
| 3 |
Gilead Sciences
GILD
|
$838K |
| 4 |
AstraZeneca
AZN
|
$799K |
| 5 |
UroGen Pharma
URGN
|
$370K |
Sector Composition
| 1 | Technology | 42.31% |
| 2 | Consumer Discretionary | 23.83% |
| 3 | Healthcare | 17.99% |
| 4 | Communication Services | 11.66% |
| 5 | Financials | 2.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Costco
COST
$418B
| $1.37M | 0.35% |
1,451
-31
| -2% | -$29.3K |
|
27
AbbVie
ABBV
$374B
| $705K | 0.18% |
3,364
-933
| -22% | -$195K |
|
28
JPMorgan Chase
JPM
$829B
| $631K | 0.16% |
2,574
-180
| -7% | -$44.2K |
|
29
Johnson & Johnson
JNJ
$427B
| $613K | 0.15% |
3,698
-21
| -0.6% | -$3.48K |
|
30
Abbott
ABT
$231B
| $542K | 0.14% |
4,085
-1,553
| -28% | -$206K |
|
31
Deere & Co
DE
$129B
| $466K | 0.12% |
992
-20
| -2% | -$9.39K |
|
32
Merck
MRK
$214B
| $443K | 0.11% |
4,932
-50
| -1% | -$4.49K |
|
33
Visa
V
$683B
| $354K | 0.09% |
1,009
| – | – |
|
34
Caterpillar
CAT
$196B
| $351K | 0.09% |
1,064
-20
| -2% | -$6.6K |
|
|
35
Gilead Sciences
GILD
$140B
| $323K | 0.08% |
2,887
-7,476
| -72% | -$838K |
|
36
Nucor
NUE
$34.1B
| $292K | 0.07% |
2,425
| – | – |
|
37
Oracle
ORCL
$633B
| $282K | 0.07% |
2,014
+65
| +3% | +$9.09K |
|
38
Duke Energy
DUK
$95.3B
| $225K | 0.06% |
+1,848
| New | +$225K |
|
39
Paychex
PAYX
$50.1B
| $224K | 0.06% |
1,455
| – | – |
|
40
American Electric Power
AEP
$59.4B
| $224K | 0.06% |
+2,050
| New | +$224K |
|
|
41
AstraZeneca
AZN
$249B
| – | – |
-12,202
| Closed | -$799K |
|
42
BioCryst Pharmaceuticals
BCRX
$1.74B
| – | – |
-23,710
| Closed | -$178K |
|
43
Evolus
EOLS
$494M
| – | – |
-25,070
| Closed | -$277K |
|
|
44
Five Below
FIVE
$8B
| – | – |
-27,048
| Closed | -$2.84M |
|
45
Pulse Biosciences
PLSE
$1.05B
| – | – |
-11,590
| Closed | -$202K |
|
46
Summit Therapeutics
SMMT
$17.7B
| – | – |
-11,496
| Closed | -$205K |
|
47
T Rowe Price
TROW
$23.6B
| – | – |
-1,770
| Closed | -$200K |
|
|
48
UroGen Pharma
URGN
$900M
| – | – |
-34,701
| Closed | -$370K |
|
|
CMRX
49
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-10,609
| Closed | -$36.9K |
|